Search research articles
Contact Us
Filters
Showing results (1-10 of 29) with videos related to
Page
of 3
Sort By:
Frontiers in Immunology
|
August 26, 2022
Sex bias in multiple sclerosis and neuromyelitis optica spectrum disorders: How it influences clinical course, MRI parameters and prognosis
Petra Nytrova, Ondrej Dolezal
Neuro Endocrinology Letters
|
February 9, 2013
Coincidence of spinal tumor (astrocytoma) and non-specific encephalomyelitis
Andrea Burgetova, Manuela Vaneckova, Petra Nytrova, et al.
Biomed Research International
|
June 9, 2020
Deep Gray Matter Iron Content in Neuromyelitis Optica and Multiple Sclerosis
Adam Pudlac, Andrea Burgetova, Petr Dusek, et al.
European Journal of Neurology
|
November 28, 2023
COVID-19 vaccination and relapse activity: A nationwide cohort study of patients with multiple sclerosis in Denmark
Dominika Stastna, Frederik Elberling, Luigi Pontieri, et al.
Plos One
|
March 25, 2024
Natalizumab promotes anti-inflammatory and repair effects in multiple sclerosis
Ragnhild Reehorst Lereim, Petra Nytrova, Astrid Guldbrandsen, et al.
Plos One
|
June 22, 2012
Evaluation of a multiparametric immunofluorescence assay for standardization of neuromyelitis optica serology
Letizia Granieri, Fabiana Marnetto, Paola Valentino, et al.
Journal of Neuroimmunology
|
August 12, 2014
Complement activation in patients with neuromyelitis optica
Petra Nytrova, Eliska Potlukova, David Kemlink, et al.
Journal of Neuroimmunology
|
October 24, 2009
Western blot analysis for the detection of serum antibodies recognizing linear Aquaporin-4 epitopes in patients with Neuromyelitis Optica
Fabiana Marnetto, Bianca Hellias, Letizia Granieri, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
March 24, 2015
Myelin oligodendrocyte glycoprotein antibodies are associated with a non-MS course in children
Yael Hacohen, Michael Absoud, Kumaran Deiva, et al.
Clinical Immunology (Orlando, Fla.)
|
August 13, 2024
Patients with multiple sclerosis who develop immunogenicity to interferon-beta have distinct transcriptomic and proteomic signatures prior to treatment which are associated with disease severity
Leda Coelewij, Marsilio Adriani, Pierre Dönnes, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 29) with videos related to
Sort By:
Page
of 3
Frontiers in Immunology
|
August 26, 2022
Sex bias in multiple sclerosis and neuromyelitis optica spectrum disorders: How it influences clinical course, MRI parameters and prognosis
Petra Nytrova, Ondrej Dolezal
Neuro Endocrinology Letters
|
February 9, 2013
Coincidence of spinal tumor (astrocytoma) and non-specific encephalomyelitis
Andrea Burgetova, Manuela Vaneckova, Petra Nytrova, et al.
Biomed Research International
|
June 9, 2020
Deep Gray Matter Iron Content in Neuromyelitis Optica and Multiple Sclerosis
Adam Pudlac, Andrea Burgetova, Petr Dusek, et al.
European Journal of Neurology
|
November 28, 2023
COVID-19 vaccination and relapse activity: A nationwide cohort study of patients with multiple sclerosis in Denmark
Dominika Stastna, Frederik Elberling, Luigi Pontieri, et al.
Plos One
|
March 25, 2024
Natalizumab promotes anti-inflammatory and repair effects in multiple sclerosis
Ragnhild Reehorst Lereim, Petra Nytrova, Astrid Guldbrandsen, et al.
Plos One
|
June 22, 2012
Evaluation of a multiparametric immunofluorescence assay for standardization of neuromyelitis optica serology
Letizia Granieri, Fabiana Marnetto, Paola Valentino, et al.
Journal of Neuroimmunology
|
August 12, 2014
Complement activation in patients with neuromyelitis optica
Petra Nytrova, Eliska Potlukova, David Kemlink, et al.
Journal of Neuroimmunology
|
October 24, 2009
Western blot analysis for the detection of serum antibodies recognizing linear Aquaporin-4 epitopes in patients with Neuromyelitis Optica
Fabiana Marnetto, Bianca Hellias, Letizia Granieri, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
March 24, 2015
Myelin oligodendrocyte glycoprotein antibodies are associated with a non-MS course in children
Yael Hacohen, Michael Absoud, Kumaran Deiva, et al.
Clinical Immunology (Orlando, Fla.)
|
August 13, 2024
Patients with multiple sclerosis who develop immunogenicity to interferon-beta have distinct transcriptomic and proteomic signatures prior to treatment which are associated with disease severity
Leda Coelewij, Marsilio Adriani, Pierre Dönnes, et al.
Page
of 3